Estimation and comparison of salivary secretory leukocyte protease inhibitor in human immunodeficiency virus patients and healthy individuals

scientific article published on January 2014

Estimation and comparison of salivary secretory leukocyte protease inhibitor in human immunodeficiency virus patients and healthy individuals is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4103/0973-1075.125551
P932PMC publication ID3931238
P698PubMed publication ID24600179

P2093author name stringKumar Pushpanshu
Rachna Kaushik
Ramhari S Sathawane
P2860cites workHIV in the oral cavity: virus, viral inhibitory activity, and antiviral antibodies: a reviewQ28262566
The role of the oral environment in HIV-1 transmissionQ28278090
Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virusQ28288820
Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitroQ28293679
Endogenous mucosal antiviral factors of the oral cavityQ33547138
Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunityQ33780434
Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patientsQ33997956
Oral transmission of HIV, reality or fiction? An updateQ34526020
The anti-HIV-1 activity associated with salivaQ34738486
Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluidsQ35075174
Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.Q35764264
Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milkQ36055396
Role of human beta-defensins in HIV infectionQ36467656
Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected personsQ37116400
Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age.Q43699128
Salivary secretory leukocyte protease inhibitor increases in HIV infectionQ44548017
Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmissionQ45738773
Components of saliva inactivate human immunodeficiency virusQ45840053
Classification and diagnostic criteria for oral lesions in HIV infection. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency VirusQ72578669
P433issue1
P304page(s)26-30
P577publication date2014-01-01
P1433published inIndian Journal of Palliative CareQ15710015
P1476titleEstimation and comparison of salivary secretory leukocyte protease inhibitor in human immunodeficiency virus patients and healthy individuals
P478volume20

Reverse relations

Q40686286Secretory Leukocyte Protease Inhibitor Expression and High-Risk HPV Infection in Anal Lesions of HIV-Positive Patients.cites workP2860

Search more.